Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/2002
10/29/2002CA2249014C Ds11 (kctc 0231bp), novel bacillus sp. strain and novel phytase produced by it
10/29/2002CA2215922C Methods for screening compounds for estrogenic activity
10/29/2002CA2212747C Mhc-antigen complexes for detecting and purifying antigen-specific t cells
10/29/2002CA2173102C Dna sequence coding for a bmp receptor
10/29/2002CA2112374C Novel yeast strains for the production of xylitol
10/29/2002CA2090515C Anti-feline calicivirus recombinant antibody and gene fragment encoding the same
10/29/2002CA2063431C Receptors for fibroblast growth factors
10/29/2002CA2045552C Cancer related haptoglobin
10/25/2002EP0981604A4 Targeted gene modification by parvoviral vectors
10/25/2002EP0915991A4 Nucleic acid amplification method: ramification-extension amplification method (ram)
10/24/2002WO2002084294A2 Gastrointestinal glutathione peroxidase in hepatitis c virus infections
10/24/2002WO2002084281A1 Encapsulated cell indicator system
10/24/2002WO2002084280A1 Insect ammunition vectors and methods of use to identify pesticide targets
10/24/2002WO2002084249A2 Therapeutic and diagnostic uses of antibody specificity profiles
10/24/2002WO2002083957A1 Improved cdna libraries and methods for their production
10/24/2002WO2002083955A1 Methods and compositions for nucleotide analysis
10/24/2002WO2002083954A1 Mobility-modified nucleobase polymers and methods of using same
10/24/2002WO2002083953A1 Methods for identifying small molecules that bind specific rna structural motifs
10/24/2002WO2002083950A1 Methods and compositions for treating cardiovascular disease using 10218
10/24/2002WO2002083949A1 A method for detecting hybridized nucleic acid with improved sensitivity
10/24/2002WO2002083948A1 Oligonucleotide chip composition for analyzing hepatitis c virus (hcv) genotype and detecting method thereof
10/24/2002WO2002083946A1 Method of examining allergic disease
10/24/2002WO2002083945A2 Diagnosis and treatment of cancer: i
10/24/2002WO2002083937A2 Methods using o6-alkylguanine-dna alkyltransferases
10/24/2002WO2002083936A2 Novel method for screening inhibitors of the linkage between the neuronal nitric oxide synthase associated protein and the protein inhibiting neuronal nitric oxide synthase
10/24/2002WO2002083928A2 Nucleid acid and corresponding protein entitled 158p3d2 useful in treatment and detection of cancer
10/24/2002WO2002083927A2 Universal multi-variant detection system
10/24/2002WO2002083925A2 Papaya ringspot virus genes
10/24/2002WO2002083924A2 Nucleic acid molecules relating to papaya ripening
10/24/2002WO2002083921A2 Nuleic acids and corresponding proteins useful in the detection and treatment of various cancers
10/24/2002WO2002083920A2 Nucleic acid sequences useful in the detection and treatment of various cancers
10/24/2002WO2002083919A2 Nucleic acid and corresponding protein entitled 184p1e2 useful in treatment and detection of cancer
10/24/2002WO2002083917A2 Nucleic acid and corresponding protein entitled 161p5c5 useful in treatment and detection of cancer
10/24/2002WO2002083916A2 Nucleic acid and corresponding protein entitled 162p1e6 useful in treatment and detection of cancer
10/24/2002WO2002083912A2 Production of apomictic seed
10/24/2002WO2002083911A1 Production of plants with increased tolerance to drought stress or with increased transpiration
10/24/2002WO2002083910A2 Sequence specific recombinase-based methods for producing intron containing vectors and compositions for use in practicing the same
10/24/2002WO2002083909A2 Recombinant nucleotide sequence coding for a gene
10/24/2002WO2002083908A1 Method for reversible inhibition of gene expression by modified ribonucleoproteins
10/24/2002WO2002083907A1 Process for producing target polypeptide by using uspa
10/24/2002WO2002083906A1 Mhc tetramers
10/24/2002WO2002083905A1 ss-GLUCOSIDASE HAVING EXCELLENT RESISTANCE TO GLUCOSE
10/24/2002WO2002083904A1 Regulation of human protein phosphatase 2c-like protein
10/24/2002WO2002083903A2 West nile virus epitopes and uses thereof
10/24/2002WO2002083902A2 Adenovirus serotype 30 (ad30) fiber protein and uses thereof
10/24/2002WO2002083901A2 Plant growth regulating genes, proteins and uses thereof
10/24/2002WO2002083900A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
10/24/2002WO2002083899A1 Cancer-associated genes
10/24/2002WO2002083898A1 Full-length human cdnas encoding potentially secreted proteins
10/24/2002WO2002083897A1 Transgenic non-human animals for pharmacological and toxicological studies
10/24/2002WO2002083896A2 Recombinant segmented negative strand virus with a duplicated 3' noncoding flanking sequence, and therapeutic compositions containing the same
10/24/2002WO2002083894A1 Linear nucleic acid sequence comprising repeats and lacking secondary structure
10/24/2002WO2002083893A2 Isolation of dna molecules using mercapto-aryl ligands
10/24/2002WO2002083892A2 Mutants of desoxycytidine kinase having extended enzymatic activity
10/24/2002WO2002083891A2 Nucleic acids for inhibiting hairless protein expression and methods of use thereof
10/24/2002WO2002083890A2 Use of clya hemolysin for excretion of fusion proteins
10/24/2002WO2002083889A2 Methods for the production of minicircles
10/24/2002WO2002083888A2 The use of genes encoding abc transporters to stimulate the production of secondary metabolites in biological cells
10/24/2002WO2002083887A2 Regulation of human methionine aminopeptidase-like protein
10/24/2002WO2002083886A2 Means and method for the preparation of transgenic plants resistant to viral infections
10/24/2002WO2002083883A2 Human phosphodiesterase 9a isoform
10/24/2002WO2002083880A1 Mosaic adenoviral vectors
10/24/2002WO2002083875A2 Transgenic mice containing channel activating protease 1 (cap1) gene disruptions
10/24/2002WO2002083874A2 Endothelial cell expression patterns
10/24/2002WO2002083873A2 Enzymes
10/24/2002WO2002083872A2 Methods and products of cleaving ssdna using oligonucleotides to form restriction sites
10/24/2002WO2002083871A2 Rapid and enzymeless cloning of nucleic acid fragments
10/24/2002WO2002083870A2 Pufa polyketide synthase systems and uses thereof
10/24/2002WO2002083869A2 Product and process for transformation of thraustochytriales microorganisms
10/24/2002WO2002083867A2 Ires enabled gene trapping in plants
10/24/2002WO2002083866A2 Repeat sequences of the ca125 gene and their use for diagnostic and therapeutic interventions
10/24/2002WO2002083862A2 Methods and compositions for identifying disease genes using nonsense-mediated decay inhibition
10/24/2002WO2002083860A2 Nucleic acid and corresponding protein entitled 151p3d4 useful in treatment and detection of cancer
10/24/2002WO2002083859A2 Surface proteins of streptococcus pyogenes
10/24/2002WO2002083858A2 Methods to inhibit viral replication
10/24/2002WO2002083855A2 Novel streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof
10/24/2002WO2002083854A2 Antibodies to vla-1
10/24/2002WO2002083853A2 Method for enhancing the translation and expression of recombinant proteins
10/24/2002WO2002083847A2 Cdna encoding the human alpha2 delta4 calcium channel subunit
10/24/2002WO2002083846A2 Methods of analysis and labeling of protein-protein interactions
10/24/2002WO2002083844A2 Compositions and methods for the production of betaine lipids
10/24/2002WO2002083841A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/24/2002WO2002083840A2 Compositions and methods for transepithelial transport of membrane-bounded vesicles and virions
10/24/2002WO2002083839A2 P450 single nucleotide polymorphism biochip analysis
10/24/2002WO2002083838A2 Elimination of endogenous porcine retrovirus
10/24/2002WO2002083837A1 Methods for identifying small molecules that bind specific rna structural motifs
10/24/2002WO2002083738A1 Cyclic single strand trispecific antibody
10/24/2002WO2002083736A2 G-protein coupled receptor molecules and uses thereof
10/24/2002WO2002083735A1 Novel receptor protein and dna thereof
10/24/2002WO2002083734A2 Modified calcitonin
10/24/2002WO2002083733A2 Polynucleotides and polypeptides of the ifnalpha-6 gene
10/24/2002WO2002083731A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
10/24/2002WO2002083730A1 Novel protein irsal and gene irsal encoding this protein
10/24/2002WO2002083727A2 Nucleic acid sequences of hyperplasies and tumors of the thyroid
10/24/2002WO2002083726A2 A novel zinc finger protein and uses thereof
10/24/2002WO2002083721A1 Protein cluster v
10/24/2002WO2002083720A2 Intermediates and enzymes of the non-mevalonate isoprenoid pathway
10/24/2002WO2002083717A1 Induction of spawning in crustacea
10/24/2002WO2002083715A1 Method and apparatus for fractional separation of proteins from plant material
10/24/2002WO2002083714A2 Method and system for optimizing multi-epitope nucleic acid constructs and peptides encoded thereby